Nurotron Biotechnology
Latest round
- Series D
Last raised
- Nov 2016
Total raised
- $16M
Investors
- 7
About Nurotron Biotechnology
, trading under the name Nurotron, develops and manufactures implantable neuro-electronic medical devices. The company specializes in neural stimulation technologies with a product portfolio that includes cochlear implants, auditory brainstem implants, visual prosthetics, and implantable sacral nerve stimulation systems., Ltd. develops neural stimulation-based medical devices. It has participated in multiple national-level R&D programs under China’s Five-Year Plans and was twice awarded the National Science and Technology Progress Award (2015, 2024). As of 2024, more than 20,000 individuals across Asia, Europe, and the Americas have received Nurotron cochlear implants. Nurotron provides implantable neuro-electronic products including cochlear implant systems, auditory brainstem implant systems, artificial vision prosthetics, and sacral nerve stimulation systems. Nurotron Biotechnology generates revenue through the sale of its neural implant systems and related surgical and rehabilitation services to hospitals and medical distributors in domestic and international markets.
Who invested in Nurotron Biotechnology
7 investors across 5 rounds
See all investors in Nurotron Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nurotron Biotechnology
Who invested in Nurotron Biotechnology?
Nurotron Biotechnology has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nurotron Biotechnology raised?
Nurotron Biotechnology has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Nurotron Biotechnology last raise money?
Nurotron Biotechnology's most recent round on record is a Series D, in Nov 2016.
What does Nurotron Biotechnology do?
, trading under the name Nurotron, develops and manufactures implantable neuro-electronic medical devices.
Where is Nurotron Biotechnology headquartered?
Nurotron Biotechnology is headquartered in Hangzhou, China.
Which VCs invest in companies like Nurotron Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Nurotron Biotechnology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Nurotron Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.